The lawsuit filed by the City and County of San Francisco against various pharmaceutical companies involved allegations of false marketing of opioids and failing to prevent and report suspicious opioid orders.

Settlement of the lawsuit with the payment of $24,797,604 to the City over 13 years, $3,043,340 to the City's outside counsel, and $2,254,336 to the City Attorney's Office, along with naloxone valued at $20,000,000.

The settlement will bring significant financial and material resources to the City of San Francisco.

The settlement resolves allegations of creating a public nuisance and violating the Unfair Competition Law by the defendants through their marketing and distribution practices regarding opioids.

The Board of Supervisors authorized the City Attorney to settle the action as detailed in the ordinance, pursuant to Charter Section 6.102(5).

The Controller is authorized and directed to allocate the payment of funds for the reimbursement of attorneys’ fees to the City Attorney’s Office as provided in the settlement agreement.